Article | November 13, 2020

Toronto Accelerator Fosters Made-In-Canada Approach To Cell Therapy

Source: CCRM
CCRM
Operators in a clean room in CCRM’s Centre for Cell and Vector Production, a good manufacturing practices facility located in the MaRS Centre in downtown Toronto. PHOTO: CCRM

Originally published by Canadian Manufacturing

The global pandemic has put the spotlight on health sciences and their importance to the economy.

This is according to Michael May, president and CEO of CCRM, a Toronto-based accelerator that develops and commercializes cell and gene therapies and regenerative medicine technologies.

May said, “COVID-19 has put a microscope on healthcare as a driver of not only the economy but something that can impact our lives regardless of what we’re doing.”

He continued, “It has put a positive lens on healthcare and life sciences and is helping us articulate that this is an important thing to invest in.”

However, May notes that Canada imports most of its healthcare expertise, something that CCRM is aiming to change.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Cell & Gene? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: